CPT 00912: Anesthesia for Transurethral Bladder Tumor Excision
CPT code 00912 identifies anesthesia services for transurethral excision of one or more bladder tumors. This code matters nationally because transurethral bladder tumor procedures are common urologic interventions that require specialized anesthesia care to manage patient safety, airway and hemodynamic stability, and anesthesia depth during endoscopic intravesical surgery. Appropriate use of this code affects hospital and ambulatory surgical center billing, anesthesia resource allocation, and payer coverage determinations.
Key payers in scope include Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. Readers will find a concise overview of what the code represents, the typical clinical context and site of service, and links to related anesthesia procedure codes. The publication summarizes common billing modifiers and associated anesthesia provider taxonomies, outlines related CPT anesthesia entries for transurethral procedures, and highlights typical diagnostic pairings used in claims where available.
This report is intended for billing managers, anesthesia providers, and revenue cycle professionals seeking a clear reference on clinical scope and coding relationships for CPT code 00912. Data not available in the input is explicitly noted where applicable.
Customize your policy alerts
Sign up for cpt 00912 policy alerts
Get alerted when payer policies referencing 00912 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 00912 describes anesthesia services provided for a patient undergoing excision of one or more tumors within the bladder performed through the urethra. This procedure is typically a transurethral bladder tumor excision and requires anesthesia management for endoscopic removal of bladder lesions.
Service type: Anesthesia for transurethral bladder tumor excision
Typical site of service: Ambulatory surgical center or hospital operating room, with the procedure performed via the urethra using endoscopic instruments for tumor excision.
National Reimbursement Benchmarks
For CPT 00912, the BUCA average commercial rate sits at $81.40, offering a midpoint perspective across commercial payers. Blue Cross Blue Shield’s interquartile spread (P75–P25) is $38.20, Aetna’s spread is $91.40, Cigna’s spread is $58.00, and UnitedHealth Group’s spread is $28.90. These dispersion values indicate that UnitedHealth Group has the tightest mid‑range variability while Aetna exhibits the widest variability among the listed payers, with Blue Cross Blue Shield and Cigna in between.
Looking across payers, Cigna and Aetna present higher upper-end rates but differ materially in variability; Aetna’s large spread suggests more regional or contractual inconsistency versus Cigna’s narrower but still significant spread. Blue Cross Blue Shield and UnitedHealth Group show more compact mid‑range behavior, with UnitedHealth Group the most concentrated. BUCA’s mean of $81.40 provides a single commercial benchmark within that spectrum.